Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Association of rs7688285 allelic variation coding for GLRB with fear reactivity and exposure-based therapy in patients with panic disorder and agoraphobia
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4511777
Author(s) Ridderbusch, Isabelle C.; Richter, Jan; Yang, Yunbo; Hoefler, Michael; Weber, Heike; Reif, Andreas; Hamm, Alfons; Pané-Farré, Christiane A.; Gerlach, Alexander L.; Stroehle, Andreas; Pfleiderer, Bettina; Arolt, Volker; Wittchen, Hans-Ulrich; Gloster, Andrew T.; Lang, Thomas; Helbig-Lang, Sylvia; Fehm, Lydia; Pauli, Paul; Kircher, Tilo; Lueken, Ulrike; Straube, Benjamin
Author(s) at UniBasel Gloster, Andrew
Year 2019
Title Association of rs7688285 allelic variation coding for GLRB with fear reactivity and exposure-based therapy in patients with panic disorder and agoraphobia
Journal European Neuropsychopharmacology
Volume 29
Number 10
Pages / Article-Number 1138-1151
Mesh terms Agoraphobia, therapy; Alleles; Avoidance Learning, physiology; Brain, physiopathology; Conditioning, Psychological, physiology; Fear, physiology; Functional Neuroimaging; Genotype; Humans; Implosive Therapy; Magnetic Resonance Imaging; Panic Disorder, therapy; Polymorphism, Single Nucleotide, genetics; Receptors, Glycine, genetics
Abstract The gene coding for glycine receptor beta subunits (GLRB) has been found to be related to panic disorder and agoraphobia (PD/AG) and to be associated with altered insular BOLD activation during fear conditioning, as an intermediate phenotype of defensive system reactivity in healthy subjects. In a multicenter clinical trial on PD/AG patients we investigated in three sub-samples whether GLRB allelic variation (A/G; A-allele identified as "risk") in the single nucleotide polymorphism rs7688285 was associated with autonomic (behavioral avoidance test BAT; n = 267 patients) and neural (differential fear conditioning; n = 49 patients, n = 38 controls) measures, and furthermore with responding towards exposure-based cognitive behavioral therapy (CBT, n = 184 patients). An interaction of genotype with current PD/AG diagnosis (PD/AG vs. controls; fMRI data only) and their modification after CBT was tested as well. Exploratory fMRI results prior to CBT, revealed A-allele carriers irrespective of diagnostic status to show overall higher BOLD activation in the hippocampus, motor cortex (MC) and insula. Differential activation in the MC, anterior cingulate cortex (ACC) and insula was found in the interaction genotype X diagnosis. Differential activation in ACC and hippocampus was present in differential fear learning. ACC activation was modified after treatment, while no overall rs7688285 dependent effect on clinical outcomes was found. On the behavioral level, A-allele carriers showed pronounced fear reactivity prior to CBT which partially normalized afterwards. In sum, rs7688285 variation interacts in a complex manner with PD/AG on a functional systems level and might be involved in the development of PD/AG but not in their treatment. (C) 2019 Elsevier B.V. and ECNP. All rights reserved.
Publisher Elsevier
ISSN/ISBN 0924-977X ; 1873-7862
edoc-URL https://edoc.unibas.ch/73207/
Full Text on edoc Available
Digital Object Identifier DOI 10.1016/j.euroneuro.2019.07.133
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/31444036
ISI-Number WOS:000488202400007
Document type (ISI) Journal Article, Multicenter Study, Randomized Controlled Trial
 
   

MCSS v5.8 PRO. 0.327 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
19/04/2024